Cargando…
Management of Vaginal Atrophy: Implications from the REVIVE Survey
Vulvar and vaginal atrophy (VVA) is a chronic and progressive medical condition common in postmenopausal women. Symptoms of VVA such as dyspareunia, vaginal dryness, irritation, and itching can negatively impact sexual function and quality of life. The REVIVE (REal Women’s VIews of Treatment Options...
Autores principales: | Wysocki, Susan, Kingsberg, Sheryl, Krychman, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071759/ https://www.ncbi.nlm.nih.gov/pubmed/24987271 http://dx.doi.org/10.4137/CMRH.S14498 |
Ejemplares similares
-
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
por: Kingsberg, SA, et al.
Publicado: (2010) -
Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey
por: Nappi, R. E., et al.
Publicado: (2016) -
WISDOM survey: attitudes and behaviors of physicians toward vulvar and vaginal atrophy (VVA) treatment in women including those with breast cancer history
por: Kingsberg, Sheryl A., et al.
Publicado: (2019) -
Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
por: Parish, Sharon J, et al.
Publicado: (2013) -
Evaluation and Management of Hypoactive Sexual Desire Disorder
por: Clayton, Anita H., et al.
Publicado: (2018)